Genesis IBRC India Ltd Stock Price Today (NSE: GENESIS)

Genesis IBRC India Ltd

116.90+0.00 (+0.00%)
Market Closed

Fundamental Score

...

Genesis IBRC India Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Genesis IBRC India Ltd share price today is 116.90, up +0.00% on NSE/BSE as of 23 June 2026. Genesis IBRC India Ltd (GENESIS) is a Small-cap company in the Biotechnology sector with a market capitalisation of 177.38 (Cr). The 52-week high for GENESIS share price is 184.90 and the 52-week low is 20.21. The company has a Return on Equity (ROE) of 51.62% and a debt-to-equity ratio of 0.00.

Genesis IBRC India Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
130.10
Low
103.48
Volume
522.4761904761905
Change
+7.33%

Genesis IBRC India Ltd share price chart: 7.33% return over the past month. 52-week high ₹184.90, 52-week low ₹20.21.

Genesis IBRC India Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
116.90116.90116.90116.900.00 (Cr)
116.90116.90116.90116.900.00 (Cr)
116.90116.90116.90116.900.00 (Cr)
116.90116.90116.90116.900.00 (Cr)
116.90116.90116.90116.900.00 (Cr)
116.90116.90116.90116.900.00 (Cr)
116.90116.90116.90116.900.00 (Cr)
116.90116.90116.90116.900.00 (Cr)
116.90116.90116.90116.900.00 (Cr)
116.90116.90116.90116.900.00 (Cr)

Genesis IBRC India Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
116.90116.90116.90116.90+0.00%
117.00130.10116.90116.90-0.09%
98.98118.0873.90111.95+13.10%
75.45108.4575.4598.98+31.19%
99.00104.0059.4375.45-23.79%
85.3096.2169.3589.90+5.39%
150.75150.7580.7585.30-43.42%
167.55184.90143.20143.60-14.29%
75.22164.3075.22164.30+118.43%
38.0471.6438.0471.64+88.33%
29.8238.0429.8238.04+27.57%
20.2129.8220.2129.82+47.55%

Returns & Performance

Excellent

Return on Equity (ROE)

51.62%

Profit generated per ₹1 of shareholder equity

Excellent

Return on Capital (ROCE)

51.62%

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Genesis IBRC India Ltd Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

51.82x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Good

Promoter Holding

11.33%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-101.64%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-100.00%

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

105.89%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

105.89%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.00x

Total debt ÷ equity. Below 0.5 = financially healthy

Interest Coverage Ratio

N/A

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-0.33 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Genesis IBRC India Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of GENESIS across key market metrics for learning purposes.

Positive Indicators

6 factors identified

Strong Return on Equity (51.62%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (51.62%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Excellent EPS Growth (105.89% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (105.89% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

5 factors identified

Profit Decline Concern (-101.64%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Revenue Contraction (-100.00%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Negative Free Cash Flow (₹-0.33 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Low Promoter Commitment (11.33%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Genesis IBRC India Ltd vs Biotechnology Peers

Peer Comparison - Biotechnology

Compare Genesis IBRC India Ltd with 4 other companies in the same sector

5 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
25/100
117
₹177.38
51.62%
Excellent
51.62%
Excellent
0.0
Excellent
105.89%
Excellent
0.00%
63.7/100
757
₹37009.24
79.9
Average
20.83%
Excellent
28.50%
Excellent
0.0
Excellent
37.27%
Excellent
23.86%
Excellent
0.00%
63.6/100
372
₹3493.23
23.7
Average
9.54%
Poor
13.11%
Average
0.0
Excellent
0.26%
Average
7.48%
Good
1.66%
16/100
27
₹68.05
16.6
Average
5.68%
Poor
9.04%
Poor
0.6
Good
-3.27%
Poor
-3.35%
Poor
0.00%
24.6/100
27
₹8.81
88.1
Average
9.68%
Poor
11.83%
Average
0.0
Excellent
4.42%
Average
-0.24%
Poor
0.00%

Genesis IBRC India Ltd Quarterly Performance

Latest quarterly metrics for GENESIS — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-100.00%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-101.64%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

105.89%

Compounded annual net profit growth over 5 years

Genesis IBRC India Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for GENESIS — calculated from daily price history

0RSI 14
Oversold — RSI 0

Selling pressure is heavy — potential reversal zone.

SMA 50
104
▲ Price above SMA 50 — Short-term bullish
SMA 200
93
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
1K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Genesis IBRC India Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Genesis IBRC India Ltd (GENESIS) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Genesis IBRC India Ltd

About GENESIS (Genesis IBRC India Ltd)

Genesis IBRC India Ltd is a biotechnology company rooted in Eluru, India, with a history of developing and commercializing pro-biotic solutions. Originally incorporated in 1992 and... formerly known as SSK Lifestyles Limited, the company initially focused on leveraging the power of beneficial microorganisms to enhance productivity and sustainability across diverse agricultural sectors. Their early endeavors centered around creating pro-biotic formulations specifically tailored for aquaculture, agriculture, poultry, and animal husbandry. These products aimed to improve animal health, enhance crop yields, and promote environmentally sound practices within these industries. While the company's initial vision centered around these applications, its current operational status reflects a period of transition. Though Genesis IBRC India Ltd once actively manufactured and marketed pro-biotic products, its current activities are not substantial, according to recent reports. The shift likely reflects the dynamic nature of the biotechnology market and the challenges inherent in scaling and sustaining operations within the agricultural sector. A variety of factors could contribute to this change, including evolving market demands, shifts in regulatory landscapes, and the inherent complexities of developing and distributing effective pro-biotic solutions. The company's journey exemplifies the often-unpredictable path of biotechnology ventures, where innovation and market acceptance must align to ensure long-term viability. Despite its current status, the historical focus of Genesis IBRC India Ltd on pro-biotic solutions reveals a commitment to harnessing the potential of biological systems for practical applications. The company's initial efforts in developing products for aquaculture, agriculture, poultry, and animal husbandry demonstrate a clear understanding of the interconnectedness of these sectors and the potential for biotechnology to contribute to sustainable and efficient resource management. Whether the company will refocus and redirect its strategy to capitalize on biotechnology opportunities remains to be seen; however, its past endeavors highlight its initial aspirations within the Indian biotechnology landscape.

Company Details

Symbol:GENESIS
Industry:Biotechnology
Sector:Biotechnology

Key Leadership

Mr. Ramakrishna Subray Hegde
Company Secretary & Compliance Officer
Mr. Balakrishna Koppula
Whole Time Chairperson
Mr. Durga Venkata Vara Prasad Rao Chadalawada
Chief Financial Officer

GENESIS Share Price: Frequently Asked Questions

What is the current share price of Genesis IBRC India Ltd?

Genesis IBRC India Ltd (GENESIS) trades at ₹116.90 on NSE and BSE. Market cap ₹177.38 (Cr). Educational data only.

What is the P/E ratio of Genesis IBRC India Ltd?

Genesis IBRC India Ltd has a P/E of N/Ax vs industry average 51.82x.

What is the Bull Run score for Genesis IBRC India Ltd?

Genesis IBRC India Ltd has a Bull Run score of 25/100 based on 25+ financial parameters.

Does Genesis IBRC India Ltd pay dividends?

Genesis IBRC India Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Genesis IBRC India Ltd?

Genesis IBRC India Ltd has ROE of 51.62%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Genesis IBRC India Ltd?

Genesis IBRC India Ltd has debt-to-equity of 0.00.

Is Genesis IBRC India Ltd a good investment?

Bull Run gives Genesis IBRC India Ltd a score of 25/100. This is not investment advice — consult a SEBI-registered advisor.